Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
MastaScope launched at European Breast Cancer Conference
May 13th, 2004
Lifeline Biotechnologies (LBTT) introduced its first internally developed product, the MastaScope (formerly referred to as the Nipplescope), at the recently concluded European Breast Cancer Conference. Dr. William Reeves, Lifeline's president and founder, said he was "overwhelmed by the response and interest this conference has generated in the MastaScope." Carlo Micheletti, Lifeline's director of international sales and marketing, noted that representatives from the United Kingdom, Italy, Germany, the Netherlands, Croatia, Sweden, Finland, Russian Federation, Lebanon, Turkey, Iran, Thailand, Egypt, Libya, Brazil, Argentina, and Belgium have...
Source: Women's Health Weekly (2004-05-13)
|
